Cleared Traditional

MagnetOs Easypack Putty (K233607) - FDA 510(k) Clearance

Class II Orthopedic device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

K233607 · Kuros Biosciences B.V · Orthopedic device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Dec 2023
Decision
36d
Days
Class 2
Risk

K233607 is an FDA 510(k) clearance for the MagnetOs Easypack Putty. Classified as Filler, Bone Void, Calcium Compound (product code MQV), Class II - Special Controls.

Submitted by Kuros Biosciences B.V (Bilthoven, NL). The FDA issued a Cleared decision on December 15, 2023 after a review of 36 days - a notably fast clearance cycle.

This device falls under the Orthopedic FDA review panel, regulated under 21 CFR 888.3045 - the FDA orthopedic device regulatory framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Kuros Biosciences B.V devices

Submission Details

510(k) Number K233607 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received November 09, 2023
Decision Date December 15, 2023
Days to Decision 36 days
Submission Type Traditional
Review Panel Orthopedic (OR)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
86d faster than avg
Panel avg: 122d · This submission: 36d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code MQV Filler, Bone Void, Calcium Compound
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 888.3045
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Orthopedic devices follow this clearance model.

Regulatory Peers - MQV Filler, Bone Void, Calcium Compound

All 201
Devices cleared under the same product code (MQV) and FDA review panel - the closest regulatory comparables to K233607.
MagnetOs Granules
K232347 · Kuros Biosciences B.V · Jan 2024
MagnetOs Putty
K230736 · Kuros Biosciences B.V · Dec 2023
Tactoset® Injectable Bone Substitute
K231968 · Anika Therapeutics, Inc. · Dec 2023
SIGNAFUSE Bioactive Strip (SBS)
K233490 · Bioventus, LLC · Dec 2023
MagnetOs Flex Matrix
K233245 · Kuros Biosciences B.V · Nov 2023
OsteoFlo® HydroPutty™
K231716 · SurGenTec, LLC · Oct 2023